Science and Technology Committee
The Pfizer Board: Science and Technology Committee
The Science and Technology Committee was established in 2003. Under the terms of its Charter, the Committee is responsible for periodically examining management's direction and investment in the Company's pharmaceutical Research & Development as well as in its technology initiatives.
The Committee may meet privately with independent consultants and be free to speak directly and independently with any members of management in discharging its responsibilities.
| Board Member | Independent | Position |
|---|---|---|
| Dennis A. Ausiello | Yes | Chair |
| M. Anthony Burns | Yes | Member |
| W. Don Cornwell | Yes | Member |
| Frances D. Fergusson | Yes | Member |
| Helen H. Hobbs | Yes | Member |
| Constance J. Horner | Yes | Member |
| James M. Kilts | Yes | Member |
| Suzanne Nora Johnson | Yes | Member |
| Stephen W. Sanger | Yes | Member |
| Marc Tessier-Lavigne | Yes | Member |
 |
If you do not have Adobe® Reader, download it here. It is available without charge from Adobe®. This link is provided as a convenience. Pfizer is not responsible for the content of this linked page. |
Pfizer Annual Report
Gain insight into Pfizer's ownership culture and achievements.